Modest slowdown in premium growth distinguishes second-quarter financial results for MPL specialty insurers
We look at the financial results for medical professional liability (MPL) insurers for the second quarter of 2022.
This research paper examines the prevalence of rare diseases in a U.S. commercial population using claims data. ICD-10 diagnosis codes associated with rare disease were sourced from Orphanet, a prominent worldwide repository for rare disease data. In the analysis, 19% of the commercially-insured population was observed to have at least one ICD-10 diagnosis code associated with a rare disease, which suggests that many ICD-10 diagnosis codes for rare diseases are too broadly defined. This report discusses the benefits of increased specificity in ICD-10 codes and offers suggestions to enable more accurate identification of rare diseases in claims data.
Prevalence of rare disease in a commercial population using ICD-10 diagnosis codes
Regenerative and targeted therapies increase the need to accurately identify rare diseases, and increased specificity in diagnosis codes of the ICD-10 could help